Profiling of the Human Natural Killer Cell Receptor-Ligand Repertoire
Natural killer (NK) cells are among the first responders to viral infections. The ability of NK cells to rapidly recognize and kill virally infected cells is regulated by their expression of germline-encoded inhibitory and activating receptors. The engagement of these receptors by their cognate liga...
Uloženo v:
| Vydáno v: | Journal of visualized experiments číslo 165 |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
19.11.2020
|
| Témata: | |
| ISSN: | 1940-087X, 1940-087X |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Natural killer (NK) cells are among the first responders to viral infections. The ability of NK cells to rapidly recognize and kill virally infected cells is regulated by their expression of germline-encoded inhibitory and activating receptors. The engagement of these receptors by their cognate ligands on target cells determines whether the intercellular interaction will result in NK cell killing. This protocol details the design and optimization of two complementary mass cytometry (CyTOF) panels. One panel was designed to phenotype NK cells based on receptor expression. The other panel was designed to interrogate expression of known ligands for NK cell receptors on several immune cell subsets. Together, these two panels allow for the profiling of the human NK cell receptor-ligand repertoire. Furthermore, this protocol also details the process by which we stain samples for CyTOF. This process has been optimized for improved reproducibility and standardization. An advantage of CyTOF is its ability to measure over 40 markers in each panel, with minimal signal overlap, allowing researchers to capture the breadth of the NK cell receptor-ligand repertoire. Palladium barcoding also reduces inter-sample variation, as well as consumption of reagents, making it easier to stain samples with each panel in parallel. Limitations of this protocol include the relatively low throughput of CyTOF and the inability to recover cells after analysis. These panels were designed for the analysis of clinical samples from patients suffering from acute and chronic viral infections, including dengue virus, human immunodeficiency virus (HIV), and influenza. However, they can be utilized in any setting to investigate the human NK cell receptor-ligand repertoire. Importantly, these methods can be applied broadly to the design and execution of future CyTOF panels. |
|---|---|
| AbstractList | Natural killer (NK) cells are among the first responders to viral infections. The ability of NK cells to rapidly recognize and kill virally infected cells is regulated by their expression of germline-encoded inhibitory and activating receptors. The engagement of these receptors by their cognate ligands on target cells determines whether the intercellular interaction will result in NK cell killing. This protocol details the design and optimization of two complementary mass cytometry (CyTOF) panels. One panel was designed to phenotype NK cells based on receptor expression. The other panel was designed to interrogate expression of known ligands for NK cell receptors on several immune cell subsets. Together, these two panels allow for the profiling of the human NK cell receptor-ligand repertoire. Furthermore, this protocol also details the process by which we stain samples for CyTOF. This process has been optimized for improved reproducibility and standardization. An advantage of CyTOF is its ability to measure over 40 markers in each panel, with minimal signal overlap, allowing researchers to capture the breadth of the NK cell receptor-ligand repertoire. Palladium barcoding also reduces inter-sample variation, as well as consumption of reagents, making it easier to stain samples with each panel in parallel. Limitations of this protocol include the relatively low throughput of CyTOF and the inability to recover cells after analysis. These panels were designed for the analysis of clinical samples from patients suffering from acute and chronic viral infections, including dengue virus, human immunodeficiency virus (HIV), and influenza. However, they can be utilized in any setting to investigate the human NK cell receptor-ligand repertoire. Importantly, these methods can be applied broadly to the design and execution of future CyTOF panels. Natural killer (NK) cells are among the first responders to viral infections. The ability of NK cells to rapidly recognize and kill virally infected cells is regulated by their expression of germline-encoded inhibitory and activating receptors. The engagement of these receptors by their cognate ligands on target cells determines whether the intercellular interaction will result in NK cell killing. This protocol details the design and optimization of two complementary mass cytometry (CyTOF) panels. One panel was designed to phenotype NK cells based on receptor expression. The other panel was designed to interrogate expression of known ligands for NK cell receptors on several immune cell subsets. Together, these two panels allow for the profiling of the human NK cell receptor-ligand repertoire. Furthermore, this protocol also details the process by which we stain samples for CyTOF. This process has been optimized for improved reproducibility and standardization. An advantage of CyTOF is its ability to measure over 40 markers in each panel, with minimal signal overlap, allowing researchers to capture the breadth of the NK cell receptor-ligand repertoire. Palladium barcoding also reduces inter-sample variation, as well as consumption of reagents, making it easier to stain samples with each panel in parallel. Limitations of this protocol include the relatively low throughput of CyTOF and the inability to recover cells after analysis. These panels were designed for the analysis of clinical samples from patients suffering from acute and chronic viral infections, including dengue virus, human immunodeficiency virus (HIV), and influenza. However, they can be utilized in any setting to investigate the human NK cell receptor-ligand repertoire. Importantly, these methods can be applied broadly to the design and execution of future CyTOF panels.Natural killer (NK) cells are among the first responders to viral infections. The ability of NK cells to rapidly recognize and kill virally infected cells is regulated by their expression of germline-encoded inhibitory and activating receptors. The engagement of these receptors by their cognate ligands on target cells determines whether the intercellular interaction will result in NK cell killing. This protocol details the design and optimization of two complementary mass cytometry (CyTOF) panels. One panel was designed to phenotype NK cells based on receptor expression. The other panel was designed to interrogate expression of known ligands for NK cell receptors on several immune cell subsets. Together, these two panels allow for the profiling of the human NK cell receptor-ligand repertoire. Furthermore, this protocol also details the process by which we stain samples for CyTOF. This process has been optimized for improved reproducibility and standardization. An advantage of CyTOF is its ability to measure over 40 markers in each panel, with minimal signal overlap, allowing researchers to capture the breadth of the NK cell receptor-ligand repertoire. Palladium barcoding also reduces inter-sample variation, as well as consumption of reagents, making it easier to stain samples with each panel in parallel. Limitations of this protocol include the relatively low throughput of CyTOF and the inability to recover cells after analysis. These panels were designed for the analysis of clinical samples from patients suffering from acute and chronic viral infections, including dengue virus, human immunodeficiency virus (HIV), and influenza. However, they can be utilized in any setting to investigate the human NK cell receptor-ligand repertoire. Importantly, these methods can be applied broadly to the design and execution of future CyTOF panels. |
| Author | Vergara, Rosemary Simpson, Laura J. Kronstad, Lisa M. Rustagi, Arjun Vendrame, Elena Ranganath, Thanmayi Blish, Catherine A. McKechnie, Julia L. Zhao, Nancy Q. Ivison, Geoffrey T. |
| AuthorAffiliation | 3 Chan-Zuckerberg BioHub 1 Department of Medicine, Stanford University School of Medicine 2 Program in Immunology, Stanford University School of Medicine |
| AuthorAffiliation_xml | – name: 1 Department of Medicine, Stanford University School of Medicine – name: 2 Program in Immunology, Stanford University School of Medicine – name: 3 Chan-Zuckerberg BioHub |
| Author_xml | – sequence: 1 givenname: Elena surname: Vendrame fullname: Vendrame, Elena – sequence: 2 givenname: Julia L. surname: McKechnie fullname: McKechnie, Julia L. – sequence: 3 givenname: Thanmayi surname: Ranganath fullname: Ranganath, Thanmayi – sequence: 4 givenname: Nancy Q. surname: Zhao fullname: Zhao, Nancy Q. – sequence: 5 givenname: Arjun surname: Rustagi fullname: Rustagi, Arjun – sequence: 6 givenname: Rosemary surname: Vergara fullname: Vergara, Rosemary – sequence: 7 givenname: Geoffrey T. surname: Ivison fullname: Ivison, Geoffrey T. – sequence: 8 givenname: Lisa M. surname: Kronstad fullname: Kronstad, Lisa M. – sequence: 9 givenname: Laura J. surname: Simpson fullname: Simpson, Laura J. – sequence: 10 givenname: Catherine A. surname: Blish fullname: Blish, Catherine A. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33283785$$D View this record in MEDLINE/PubMed |
| BookMark | eNpdkVtLwzAUx4NM3MV9BemLIEg1l7ZJXwQZ04lDRRR8C2mabpG2mUkq-O3N3BzTl3Ph_Pif2xD0WtMqAMYIXhCao8sM5QgfgAHKExhDRt96e3EfDJ17hzDDMGVHoE8IZoSydACmT9ZUutbtIjJV5JcqmnWNaKMH4Tsr6uhe17Wy0UTVdfSspFp5Y-O5Xoi2DPlKWW-0VcfgsBK1U-OtH4HXm-nLZBbPH2_vJtfzWJKM-DhXIoU5KfIElVSUsKKiKBLFMiFwCWnJGE1ThmEJCYMSF0URClmFEkQymhaSjMDVRnfVFY0qpWp9GJKvrG6E_eJGaP630uolX5hPTnOSEoyCwNlWwJqPTjnPG-1kWE60ynSO4ySjLAkmCejJfq9dk9_bBeB0A0hrnLOq2iEI8vVP-M9PAnf-j5PaC6_NekRd_6O_AcOvi-E |
| CitedBy_id | crossref_primary_10_3389_fbioe_2025_1557021 crossref_primary_10_1016_j_virol_2024_110318 crossref_primary_10_1084_jem_20210582 crossref_primary_10_3389_fcimb_2022_757846 crossref_primary_10_1038_s41590_023_01560_8 |
| ContentType | Journal Article |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| DOI | 10.3791/61912 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1940-087X |
| ExternalDocumentID | PMC7935321 33283785 10_3791_61912 |
| Genre | Video-Audio Media Research Support, U.S. Gov't, Non-P.H.S Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R21 AI135287 – fundername: NIAID NIH HHS grantid: K08 AI138640 – fundername: NIAID NIH HHS grantid: UM1 AI068636 – fundername: NIAID NIH HHS grantid: T32 AI007290 – fundername: NIAID NIH HHS grantid: R01 AI131798 – fundername: NIAID NIH HHS grantid: T32 AI007502 – fundername: NCATS NIH HHS grantid: TL1 TR001084 – fundername: NIDA NIH HHS grantid: DP1 DA046089 – fundername: NIAID NIH HHS grantid: U01 AI068636 – fundername: NIAID NIH HHS grantid: U19 AI057229 |
| GroupedDBID | --- 223 29L 53G 5GY AAHBH AAHTB AAYXX ABPEJ ACGFO ADBBV AKRSQ ALMA_UNASSIGNED_HOLDINGS BAWUL CITATION CS3 E3Z GX1 OK1 RPM SJN CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c363t-9ea5093b941d7ad0f7abb4e86aa2d07d88755820d0380c2bbbaa26f1413675bc3 |
| IEDL.DBID | 223 |
| ISICitedReferencesCount | 7 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000596845500032&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1940-087X |
| IngestDate | Thu Aug 21 13:59:06 EDT 2025 Fri Jul 11 10:16:53 EDT 2025 Thu Jan 02 22:28:04 EST 2025 Sat Nov 29 02:30:18 EST 2025 Tue Nov 18 21:02:39 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 165 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c363t-9ea5093b941d7ad0f7abb4e86aa2d07d88755820d0380c2bbbaa26f1413675bc3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 These authors contributed equally |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/7935321 |
| PMID | 33283785 |
| PQID | 2467844674 |
| PQPubID | 23479 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7935321 proquest_miscellaneous_2467844674 pubmed_primary_33283785 crossref_primary_10_3791_61912 crossref_citationtrail_10_3791_61912 |
| PublicationCentury | 2000 |
| PublicationDate | 20201119 |
| PublicationDateYYYYMMDD | 2020-11-19 |
| PublicationDate_xml | – month: 11 year: 2020 text: 20201119 day: 19 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Journal of visualized experiments |
| PublicationTitleAlternate | J Vis Exp |
| PublicationYear | 2020 |
| SSID | ssj0062058 |
| Score | 2.2705896 |
| Snippet | Natural killer (NK) cells are among the first responders to viral infections. The ability of NK cells to rapidly recognize and kill virally infected cells is... |
| SourceID | pubmedcentral proquest pubmed crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| SubjectTerms | Antibodies - metabolism Cell Line DNA - metabolism Freeze Drying Humans Intercalating Agents - metabolism Killer Cells, Natural - immunology Ligands Receptors, Natural Killer Cell - metabolism Reproducibility of Results Staining and Labeling |
| Title | Profiling of the Human Natural Killer Cell Receptor-Ligand Repertoire |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/33283785 https://www.proquest.com/docview/2467844674 https://pubmed.ncbi.nlm.nih.gov/PMC7935321 |
| WOSCitedRecordID | wos000596845500032&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVDIW databaseName: Journal of Visualized Experiments : JoVE customDbUrl: eissn: 1940-087X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0062058 issn: 1940-087X databaseCode: 223 dateStart: 0 isFulltext: true titleUrlDefault: https://www.jove.com/journal providerName: Journal of Visualized Experiments |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3dS8MwED-GqAji90f9mBH2WuzStGkeZSiCMvagsLeSNFcdjG7MKfjfe0nndFPwpVCShnAX7n7XJL8fQMsxqqCKopDQsaQCBUWYlUqEglJ3wnVphNJebEJ2u1m_r3oNuPhzBz-Wqn1FCN-rCDtmdMfc_B1pUx55_U2qw92ZLNlfh82FrxZzzS8AuXwO8kdiud3-d0o7sDXDjOy6dvIuNLDag7VaRfJjH256XnebchAblYwAHfN_5llXe04Ndu-v-7EODoeMUCKOqcwOHwbPurL0PsbJdERx7wCebm8eO3fhTB0hLOI0noYKNSX72CjRtlLbqJTaGIFZqjW3kbQUPZKE8ruNyHIFN8ZQQ1q2hSNpS0wRH8JKNarwGFiJhUWJmGbIhbVKo7E24opGK5AAYwCtLzvmxYw63ClYDHMqIZxFcm-RAJrzbuOaK2O5w-WXE3JaxW5rQlc4envNOcXrTDjlkwCOaqfMh4hjx9CTJQHIBXfNOziG7MWWavDimbIp-CQxb5_8N7FT2OCujnbH-9QZrEwnb3gOq8X7dPA6afpFR0_Zzz4B2BHQ1g |
| linkProvider | Journal of Visualized Experiments |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Profiling+of+the+Human+Natural+Killer+Cell+Receptor-Ligand+Repertoire&rft.jtitle=Journal+of+visualized+experiments&rft.au=Vendrame%2C+Elena&rft.au=McKechnie%2C+Julia+L.&rft.au=Ranganath%2C+Thanmayi&rft.au=Zhao%2C+Nancy+Q.&rft.date=2020-11-19&rft.issn=1940-087X&rft.eissn=1940-087X&rft.issue=165&rft_id=info:doi/10.3791%2F61912&rft.externalDBID=n%2Fa&rft.externalDocID=10_3791_61912 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1940-087X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1940-087X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1940-087X&client=summon |